PHAT
Closed
Phathom Pharmaceuticals Inc
8.85
-0.74 (-7.72%)
Last Update: 01 Jul 2025 23:18:00
Yesterday: 9.59
Day's Range: 8.72 - 9.5098
Send
sign up or login to leave a comment!
When Written:
7.7
Phathom Pharmaceuticals Inc. is a biopharmaceutical company that focuses on the development and commercialization of treatments for gastrointestinal diseases. The company was founded in 2018 and is headquartered in Buffalo Grove, Illinois.
Phathom's lead product candidate is vonoprazan, a proton pump inhibitor that is being developed for the treatment of gastroesophageal reflux disease (GERD) and other acid-related disorders. Vonoprazan has been approved in Japan and is currently in Phase 3 clinical trials in the United States.
In addition to vonoprazan, Phathom has a pipeline of other product candidates in various stages of development for the treatment of gastrointestinal diseases, including eosinophilic esophagitis and peptic ulcer disease.
Phathom is led by a team of experienced executives with a track record of success in the pharmaceutical industry. The company has partnerships with Takeda Pharmaceuticals and other organizations to support the development and commercialization of its products.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Phathom's lead product candidate is vonoprazan, a proton pump inhibitor that is being developed for the treatment of gastroesophageal reflux disease (GERD) and other acid-related disorders. Vonoprazan has been approved in Japan and is currently in Phase 3 clinical trials in the United States.
In addition to vonoprazan, Phathom has a pipeline of other product candidates in various stages of development for the treatment of gastrointestinal diseases, including eosinophilic esophagitis and peptic ulcer disease.
Phathom is led by a team of experienced executives with a track record of success in the pharmaceutical industry. The company has partnerships with Takeda Pharmaceuticals and other organizations to support the development and commercialization of its products.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








